Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
Zhou’s study, "TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming," was recently published in Circulation. The most common cause of death worldwide is ...